BEGHETTO, Barbara
 Distribuzione geografica
Continente #
NA - Nord America 6.176
EU - Europa 4.393
AS - Asia 3.415
SA - Sud America 420
AF - Africa 67
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 4
Totale 14.487
Nazione #
US - Stati Uniti d'America 6.066
IT - Italia 1.679
GB - Regno Unito 1.056
CN - Cina 1.024
SG - Singapore 996
SE - Svezia 441
HK - Hong Kong 370
VN - Vietnam 334
BR - Brasile 327
DE - Germania 298
TR - Turchia 228
FI - Finlandia 177
UA - Ucraina 176
FR - Francia 146
RU - Federazione Russa 114
KR - Corea 107
IN - India 104
BG - Bulgaria 61
NL - Olanda 59
CA - Canada 52
BD - Bangladesh 42
MX - Messico 38
AR - Argentina 34
ID - Indonesia 33
PL - Polonia 25
IQ - Iraq 24
LT - Lituania 21
ES - Italia 19
IE - Irlanda 19
IR - Iran 18
PK - Pakistan 18
BE - Belgio 17
CO - Colombia 16
SA - Arabia Saudita 15
ZA - Sudafrica 15
IL - Israele 14
JP - Giappone 13
EC - Ecuador 12
SI - Slovenia 12
AT - Austria 11
CH - Svizzera 11
EU - Europa 11
CL - Cile 9
MA - Marocco 9
AE - Emirati Arabi Uniti 8
DZ - Algeria 8
PH - Filippine 8
TH - Thailandia 8
EG - Egitto 7
MY - Malesia 7
NG - Nigeria 7
UZ - Uzbekistan 7
CZ - Repubblica Ceca 6
GR - Grecia 6
JO - Giordania 6
PE - Perù 6
RO - Romania 6
VE - Venezuela 6
BY - Bielorussia 5
DK - Danimarca 5
KE - Kenya 5
TN - Tunisia 5
AU - Australia 4
DO - Repubblica Dominicana 4
KZ - Kazakistan 4
PA - Panama 4
PY - Paraguay 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
UY - Uruguay 4
CR - Costa Rica 3
GE - Georgia 3
JM - Giamaica 3
NP - Nepal 3
SN - Senegal 3
TW - Taiwan 3
AL - Albania 2
AZ - Azerbaigian 2
BH - Bahrain 2
BO - Bolivia 2
CU - Cuba 2
CY - Cipro 2
EE - Estonia 2
ET - Etiopia 2
KG - Kirghizistan 2
LB - Libano 2
LV - Lettonia 2
MD - Moldavia 2
MG - Madagascar 2
NI - Nicaragua 2
PT - Portogallo 2
QA - Qatar 2
TJ - Tagikistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
CI - Costa d'Avorio 1
GA - Gabon 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
Totale 14.478
Città #
Southend 781
Santa Clara 756
Singapore 672
Ashburn 519
Woodbridge 461
Fairfield 389
Chandler 385
Hong Kong 363
Jacksonville 323
Hefei 285
Ann Arbor 251
Houston 239
Nyköping 235
Beijing 233
Dearborn 223
San Jose 207
Wilmington 182
Rome 161
London 150
Cambridge 143
Milan 138
Seattle 137
Izmir 123
Dallas 121
Helsinki 110
Los Angeles 105
Seoul 105
Ho Chi Minh City 95
The Dalles 84
Hanoi 72
Naples 69
New York 69
Princeton 67
Buffalo 63
Sofia 58
Eugene 57
Frankfurt am Main 57
Chicago 56
Modena 56
San Diego 54
Council Bluffs 50
Lauterbourg 48
Shanghai 44
Munich 38
Moscow 34
São Paulo 33
Bari 32
Bologna 32
Florence 30
Des Moines 29
Palermo 29
Da Nang 26
Orem 25
Chennai 23
Turin 21
Brescia 19
Guangzhou 19
Philadelphia 19
Catania 18
Dublin 17
Mexico City 17
Brussels 16
Elk Grove Village 16
Mumbai 16
Warsaw 16
Columbus 15
Falkenstein 15
Jakarta 15
Boardman 14
Nanjing 14
Salt Lake City 14
Augusta 13
Bremen 13
Haiphong 13
Montreal 13
San Mateo 13
Turku 13
Baghdad 12
Johannesburg 12
Phoenix 12
Stockholm 12
Atlanta 11
Brooklyn 11
Redwood City 11
Denver 10
Ferrara 10
Kent 10
Kunming 10
Mashhad 10
Norwalk 10
Parma 10
Shenzhen 10
Tokyo 10
Toronto 10
Amsterdam 9
Changsha 9
Ottawa 9
Perugia 9
Pescara 9
Tampa 9
Totale 9.721
Nome #
Un raro caso di prostatite da Candida albicans, Candida krusei ed Enterococcus fecium 1.711
Multidisciplinary approach to the treatment of metabolic and morphologic alterations of HIV-related lipodystrophy 352
Aging with HIV vs. HIV Seroconversion at Older Age: A Diverse Population with Distinct Comorbidity Profiles 348
18Fluoride-based molecular imaging of coronary atherosclerosis in HIV infected patients 308
Molecular Imaging of Vascular Calcification with 18 F-Sodium-Fluoride in Patients Infected with Human Immunodeficiency Virus 303
Long-term psychometric outcomes of facial lipoatrophy therapy: Forty-eight-week observational, nonrandomized study 296
The natural history of HIV-associated lipodystrophy in the changing scenario of HIV infection 289
Alendronate reduces bone turnover in HIV-associated Osteopenia and Osteoporosis 284
Autologous fat transfer for treating facial wasting in HIV body fat redistribution syndrome. 280
Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study 278
Detectable HIV viral load is associated with metabolic syndrome 276
Associatioin of epicardial adipose tissue with incident coronary heart disease and death in HIV infected patients. 274
Successful Pre- and Posttransplant Sofosbuvir-Based Anti-Hepatitis C Virus Treatment in Persons Living With Human Immunodeficiency Virus Infection 273
Prediction of hard cardiovascular events in HIV patients 271
Autologous fat transfer for treating facial wasting in HIV-related lipodystrophy: experience of 53 treated patients 265
A randomized, controlled trial to evaluate change in cardiometabolic and endothelial function in HIV-infected patients with optimal viral suppression on Darunavir/ritonavir monotherapy vs. triple-therapy. 255
Psychometric evaluation of patients undergoing surgical treatment of HIV-related facial lipoatrophy 252
Effectiveness and durability of polyacrylamide hydrogel injections for treating HIV-related facial lipoatrophy 252
Age-related comorbidities in people living with HIV 249
Prevalence of and risk factors for pubic lipoma development in HIV-infected persons 231
Prospective, partially randomized, 24-week study to compare the efficacy and durability of different surgical techniques and interventions for the treatment of HIV-related facial lipoatrophy 229
Severity of lipodystrophy is associated with decreased health-related quality of life 229
ISS-NIA ITALIAN COHORT: NEW ANTI-HIV INHIBITORS IN PATIENTS EXPERIENCED TO IP, NRTI, NNRTI. 223
Effects of atazanavir, darunavir, and raltegravir on fat and muscle among persons living with HIV 223
Does lipodistrophy affect quality of life? 222
Randomized Trial to Evaluate Cardiometabolic and Endothelial Function in Patients with Plasma HIV-1 RNA Suppression Switching to Darunavir/Ritonavir with or without Nucleoside Analogues 221
Autologous fat transfer for treating facial waisting in HIV body fat redistribution Syndrome 220
Body Image perception in HIV infected women with body fat redistribution. 216
Candidemia nosocomiale: quattro anni di esperienza in un'ospedale universitario italiano 214
Effectiveness and long-term durability of autologous fat transplant for HIV-related face lipoatrophy. 214
Efficacy and safety of medical and surgical interventions for treating HIV-related lipodystrophy in women 211
Psychometric evaluation in patients undergoing fillers injections for the treatment of HIV-related facial lipoatrophy: polylactic acid versus polyacrylamide 210
Morphologic alterations in HIV infected people with lipodystropy are associated with good adherence to HAART. 204
Long-term follow-up of graft hypertrophy after autologous fat transfer for HIV-related face lipoatrophy (hamster syndrome 1 year later) 203
Long lasting psycho-social benefits of polyacrylamide injections for the treatment of facial lipoatrophy 203
How do frailty mediate pathway leading to disability 198
Determinants of virologic and immunologic outcomes in chronically HIV-infected subjects undergoing repeated treatment interruptions: The Istituto Superiore di Sanità-Pulsed Antiretroviral Therapy (ISS-PART) study 195
Quality of life and body image in the assessment of psychological impact of lipodystrophy: validation of the italian version of assessment of body change and distress questionnaire 194
The role of virological and immunological parameters on the diagnosis of metabolic syndrome in HIV-associated lipodystrophy 193
È possibile un counselling HIV su internet? 193
Virologic failure and metabolic syndrome in patients with HIV infection 185
Validity of body image perception in women with HIV. 184
Limited occurrence of new grade 3-4 toxicity events with salvage regimens based on raltegravir and /or maraviroc: 96 weeks data from the ISS NIA cohort study. 181
Virologic failure and metabolic syndrome in patients with HIV infection 181
Relapse of HIV-related buffalo hump after liposuction 172
Prevalence and risk factors of pubic lipomas in HIV-infected patients 171
Mechanical and ultrasound-assisted liposuction for treating subcutaneous fat accumulations in HIV-related lipodystrophy: experience of 33 treated patients 171
Evaluating immunological and inflammatory changes of treatment-experienced people living with HIV switching from first-line triple cART regimens to DTG/3TC vs. B/F/TAF: the DEBATE trial 170
Prospective, 48 weeks follow up, multidisciplinary interventionalstudy to assess improvement of adherence in people with lipodistrophy. 167
Limited occurence of new grade 3-4 toxicity events with salvage regimens based on raltegravir and /or maraviroc: 96 weeks data from the ISS NIA cohort study 165
Hepatitis C virus antibody-positive patients with HIV infection have a high risk of insulin resistance: A cross-sectional study 162
Qual è il rapporto tra qualità di vita e lipodistrofia 160
HIV counselling looks for new target and methods web versus face to face counselling 159
Lipodystrophy and quality of life: a prospective study 157
Ruolo della chirurgia plastica nel trattamento della sindrome da ridistribuzione del tessuto adiposo 154
Nuovi obiettivi e strumenti di lavoro nel counselling HIV: studio prospettico osservazionale del counselling informatico versus il counselling vis a vis 146
Metabolic and anthropometric alterations in a population of HIV infected patients with a high prevalence of lipodystrophy: associations with HCV coinfection 136
Gender differences in depression evolution in a cohort of patients attendine a metabolic clinic for lipodystrophy management 135
Lipodistrophy is related to adherence to antiretroviral therapy (ARV) 133
HIV counselling and prevention on the WEB 128
Tenofovir treatment in HIV-related lipodystrophy syndrome. Retrospective observational forty-eight weeks follow-up study 119
Totale 14.598
Categoria #
all - tutte 46.970
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.970


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021275 0 0 0 0 0 0 0 0 0 114 96 65
2021/2022914 21 136 62 104 23 43 34 76 95 66 142 112
2022/20231.398 140 121 111 109 121 178 38 152 180 45 107 96
2023/20241.039 60 71 81 130 165 79 91 98 34 49 60 121
2024/20252.816 113 77 60 224 589 403 214 130 336 97 259 314
2025/20264.092 309 222 473 544 541 346 508 268 498 383 0 0
Totale 14.598